Anthracyclines
Doxorubicin hydrochloride
CAS: 25316-40-9 Molecular Formula: C27H30ClNO11 Molecular Weight (g/mol): 579.98 MDL Number: MFCD00077757,MFCD00077757,MFCD00941448 InChI Key: MWWSFMDVAYGXBV-FGBJBKNOSA-N Synonym: doxorubicin hydrochloride,adriamycin,doxorubicin hcl,adriacin,adriblastina,rubex,adriamycin hydrochloride,adriblastin,adriamycin pfs PubChem CID: 129626538 IUPAC Name: hydrogen (8S,10S)-10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione chloride SMILES: [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O
Selleck Chemical LLC Doxorubicin (DOX) HCl S1208-1g
Doxorubicin (DOX) HCl is an antibiotic agent that inhibits human DNA topoisomerase I and topoisomerase II with IC50s of 0 8 M and 2 67 M respectively Doxorubicin reduces basal phosphorylation of AMPK Doxorubicin is used in the concomitant treatment of HIV-infected patients but is found to be at high risk of HBV reactivation This product may precipitate when dissolved in PBS solution It is recommended to prepare the stock solution in pure water and dilute with either pure water or saline to obtain the working solution Doxorubicin (Adriamycin) HCl can be used to induce animal models of kidney disease
Sigma Aldrich Fine Chemicals Biosciences Apoatropine hydrochloride10MG
This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity water residual solvents inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH Co. KG
Medchemexpress LLC BIIE-0246 hydrochloride | 99.1% | 896.05 g/mol | C49H57N11O6
BIIE-0246 hydrochloride is a potent, selective, non-peptide antagonist of the neuropeptide Y Y2 receptor (NPY2R) used in pharmacological and neuroscience research. Supplied as a white to off-white solid, the compound is offered as bulk material and as pre-made DMSO solutions for in vitro studies. Documentation such as COA, SDS, and analytical reports are available to support experimental reproducibility.
- Potent and selective NPY Y2 receptor antagonist for research applications.
- High purity (reported at 99.1%), reducing variability in assays.
- Available as solid material and as pre-made DMSO solutions for convenience.
- White to off-white solid appearance suitable for laboratory handling.
- Stability data provided for powder and solutions to aid storage planning.
- Analytical documentation (COA, HNMR, HPLC) available to verify quality.
Medchemexpress LLC BIIE-0246 | 246146-55-4 | 99.1% | 896.05 g·mol⁻¹ | C49H57N11O6 | 1 ML
BIIE-0246 is a potent, selective non-peptide antagonist of the neuropeptide Y Y2 receptor (NPY2R) used in preclinical neuroscience research. It has an IC50 of approximately 15 nM (rat [125I]PYY3-36) and modulates downstream signaling pathways including p-AKT and p44/42 MAPK. The compound is supplied as a 10 mM solution in DMSO with reported high purity for research use only.
- Potent NPY Y2 receptor antagonist (IC50 ~15 nM).
- Ready-to-use 10 mM solution in DMSO for in vitro assays.
- High reported purity (99.1%).
- Molecular weight 896.05 g·mol⁻¹ and formula C49H57N11O6.
- Suitable for studies of NPY2R signaling and related pathways.
Medchemexpress LLC Doxorubicin-SMCC 10mM 1mL | 400647-59-8 | 1 ML
Doxorubicin-SMCC is a payload-linker conjugate that links the DNA topoisomerase II inhibitor doxorubicin to a non-cleavable SMCC linker for antibody-drug conjugate research. It is supplied as a 10 mM solution in DMSO.
- Ready-to-use 10 mM solution in DMSO, 1 mL.
- Non-cleavable SMCC linker for stable maleimide-thiol conjugation.
- Doxorubicin payload (topoisomerase II inhibitor) for potent cytotoxicity.
- High purity (98.8%) for reproducible conjugation and bioassays.
- Molecular weight 762.76 g·mol-1; formula C39H42N2O14.
- Storage: in solvent -80°C (6 months) or -20°C (1 month).
Alkali Scientific Doxorubicin Hydrochloride, Powder, 5 Milligrams
Doxorubicin Hydrochloride, 5mg is an anticancer drug used in laboratory research for testing and studying chemotherapy treatments. Doxorubicin is an anthracycline antibiotic that intercalates into DNA, inhibiting the enzyme topoisomerase II and disrupting DNA replication, which leads to cell death. This compound is widely used in cancer research to explore its effectiveness in various cancer cell lines. The 5mg vial is suitable for preparing solutions for in vitro studies of cell growth inhibition, apoptosis, and drug resistance. It is an essential reagent in preclinical and clinical research investigating cancer therapies and chemotherapy resistance mechanisms.
Cell Signaling Technology Doxorubicin, Lyophilized Powder, >99% Purity, 5 mg
Doxorubicin is an anthracycline antibiotic that serves as an effective anti-tumor agent by inhibiting DNA and RNA synthesis in mammalian cells. It functions by intercalating into the DNA double helix and stabilizing topoisomerase II cleavage complexes, which results in DNA strand breaks. Additionally, it has been demonstrated to inhibit human DNA topoisomerase I. This product is intended for research use only and not for use in diagnostic procedures.
- Formula: C27H29NO11 • HCl
- Molecular weight: 579.98 g/mol
- Purity: >99%
- Solubility: Soluble in DMSO (100 mg/ml) and water (10 mg/ml)
- Storage: -20°C, desiccated and protected from light
Medchemexpress LLC BIIE-0246 (AR-H 053591) | 246146-55-4 | 99.1% | 896.05 g/mol | C49H57N11O6 | 100 MG
BIIE-0246 (AR-H 053591) is a potent, selective non-peptide antagonist of the neuropeptide Y Y2 receptor used as a research reagent to probe NPY2R-mediated signaling. It is provided as a solid powder for in vitro and in vivo applications, with a reported IC50 of approximately 15 nM (rat [125I]PYY3-36). Intended for research use only.
- Potent, selective NPY Y2 receptor antagonist (IC50 ≈ 15 nM).
- Supplied as a solid powder suitable for in vitro and in vivo studies.
- High purity (reported ≥99.1%).
- Available in multiple pack sizes and solution formats for convenience.
- Intended for research use only; not for human or clinical use.
Medchemexpress LLC Biie-0246 (AR-H 053591) | 246146-55-4 | 99.1% | 896.05 | C49H57N11O6 | 25 MG
BIIE-0246 is a selective, non-peptide antagonist of the neuropeptide Y Y2 receptor used in pharmacological research. It exhibits potent activity (IC50 ≈ 15 nM) and modulates NPY-mediated signaling pathways, including effects on p-AKT S473 and p44/42 MAPK; it has been used in disease models such as ADR nephropathy.
- High potency at NPY Y2 receptor (IC50 ≈ 15 nM).
- High purity suitable for research applications (99.1%).
- Available as solid and as DMSO solution for flexible dosing.
- Molecular formula C49H57N11O6 and molecular weight 896.05.
- Applicable for in vitro and in vivo studies of NPY signaling and renal pathology.
Fisher Scientific Doxorubicin Hydrochloride, Fisher BioReagents
CAS: 25316-40-9 Molecular Formula: C27H30ClNO11 Molecular Weight (g/mol): 579.98 MDL Number: MFCD00077757,MFCD00077757,MFCD00941448 InChI Key: MWWSFMDVAYGXBV-FGBJBKNOSA-N Synonym: doxorubicin hydrochloride,adriamycin,doxorubicin hcl,adriacin,adriblastina,rubex,adriamycin hydrochloride,adriblastin,adriamycin pfs PubChem CID: 129626538 IUPAC Name: (7R,9R)-7-[(2S,4R,5R,6R)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride SMILES: [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O
Doxorubicin Hydrochloride, Thermo Scientific Chemicals PROMO
CAS: 25316-40-9 Molecular Formula: C27H30ClNO11 Molecular Weight (g/mol): 579.98 g/mol MDL Number: MFCD00077757,MFCD00077757,MFCD00941448 InChI Key: MWWSFMDVAYGXBV-FGBJBKNOSA-N Synonym: doxorubicin hydrochloride,adriamycin,doxorubicin hcl,adriacin,adriblastina,rubex,adriamycin hydrochloride,adriblastin,adriamycin pfs PubChem CID: 129626538 IUPAC Name: hydrogen (8S,10S)-10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione chloride SMILES: [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O